Old Web
English
Sign In
Acemap
>
authorDetail
>
R. Bukovec
R. Bukovec
Medicine
Cancer
Immunotherapy
Progressive disease
Internal medicine
4
Papers
77
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Reduction of cisplatin-induced anemia by the pineal indole 5-methoxytryptamine in metastatic lung cancer patients.
2003
Neuro endocrinology letters
Lissoni P
Fabio Malugani
R. Bukovec
Bordin
Perego Ms
Mengo S
A. Ardizzoia
Tancini G
Show All
Source
Cite
Save
Citations (7)
003 Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal
2000
Veronica Bordin
Giani L
S. Meregalli
R. Bukovec
Vaghi M
Maria L. Mandala
Winfried Hindermann
Mark J. Huller
Wendelin Werner
Johan Schubert
T.A. Serel
Müjdat Çetin
Erdal Celik
Show All
Source
Cite
Save
Citations (0)
Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patients.
2000
Urologia Internationalis
Veronica Bordin
Giani L
S. Meregalli
R. Bukovec
Vaghi M
Mario Mandalà
F. Paolorossi
A. Ardizzoia
G. Tancini
Sandro Barni
Franco Frigerio
L. Fumagalli
Bordoni A
G. Valsuani
G. Di Felice
Lissoni P
Show All
Source
Cite
Save
Citations (32)
Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease.
1999
Journal of Biological Regulators and Homeostatic Agents
Lissoni P
L. Vigore
Ferranti R
R. Bukovec
S. Meregalli
Mario Mandalà
Sandro Barni
Tancini G
Fumagalli L
Giani L
Show All
Source
Cite
Save
Citations (38)
1